Prostate Cancer

A New Radiotherapy Option for Prostate Cancer

February 21, 2012

Noninvasive brachytherapy-like treatment may be a new option for men with prostate cancer.
 

Dietary Calcium May Decrease Prostate Cancer Risk

February 17, 2012

Dietary calcium is associated with lower risk for prostate cancer (PCa), particularly among black men, and with a lower risk for high-grade prostate cancer among all men, according to a study involving 108 U.S. veterans with biopsy-positive prostate cancer, 161 biopsy-negative controls, and 237 healthy controls.
 

PCA3 Test Okayed to Help Decide Need for Repeat Prostate Biopsy

February 15, 2012

The FDA has approved the first urine-based molecular test to help determine if men who have had a prior negative prostate biopsy should undergo a repeat biopsy.
 

Researchers Find Mutation that May Hike Prostate Cancer Risk

February 14, 2012

Researchers at Johns Hopkins University in Baltimore have found a specific gene mutation that may put men at a 10-20 times greater risk of developing prostate cancer.
 

Are you more likely today to recommend active surveillance for selected patients with low-risk prostate cancer than you were five years ago?

February 13, 2012

Evidence is accumulating that active surveillance is an appropriate way to manage low-risk prostate cancer in selected men, with curative treatment delayed until it is warranted by indicators of disease progression.
 

Proton Therapy Safe, Effective for Prostate Cancer

February 08, 2012

Two new studies suggest that proton therapy is a safe and effective treatment for prostate cancer.
 

Never-Married Men Fare Worse After Prostate Cancer Surgery

February 04, 2012

SAN FRANCISCO—Prostate cancer patients who have never been married are more likely than married men to die from their disease following radical prostatectomy (RP), according to study findings presented here at the annual Genitourinary Cancers Symposium.
 

Very Low Testosterone Hikes Prostate Cancer Recurrence Risk

February 04, 2012

SAN FRANCISCO—Extremely low levels of testosterone in men after they have undergone radical prostatectomy (RP) for intermediate- to high-risk prostate cancer are associated with an elevated risk for biochemical recurrence of the disease, researchers reported here at the annual Genitourinary Cancers Symposium.
 

Brachytherapy May Be An Option for Men with High-Risk Prostate Cancer

February 04, 2012

SAN FRANCISCO—Brachytherapy may be a treatment option for patients with high-risk prostate cancer (HRPC), according to data presented here at the annual Genitourinary Cancers Symposium.
 

Prostate Cancer Linked to Heavy Alcohol Intake

February 03, 2012

SAN FRANCISCO—Heavy ethanol intake is associated with an increased risk of prostate cancer (PCa) among low-risk men with at least one prior negative prostate biopsy, investigators reported here at the annual Genitourinary Cancers Symposium. It also is associated with an elevated risk for high-grade PCa.
 

PSA Testing Rates Unchanged for Elderly Men Despite Task Force Guidelines

February 03, 2012

SAN FRANCISCO—PSA testing rates for men aged 75 years and older did not decline despite a 2008 U.S. Preventive Services Task Force (USPSTF) recommendation against PSA screening for men in this age group, according to study findings presented at the annual Genitourinary Cancers Symposium.
 

Prostate Cancer Patients Far More Likely to Die from Other Causes

February 03, 2012

SAN FRANCISCO—Elderly men who receive definitive local treatment for prostate cancer (PCa) are much more likely to die from causes other than their cancer, a finding that could inform doctor-patient discussions about treatment for localized PCa, investigators reported here at the annual Genitourinary Cancers Symposium.
 

Many Metastatic Prostate Cancers Go Untreated

February 03, 2012

SAN FRANCISCO—Many patients with metastatic prostate cancer (PCa) never receive anticancer treatment, and older age, lower income, and lack of private health insurance may be among the reasons, according to data presented here at the annual Genitourinary Cancers Symposium.
 

Novel Drug Prolongs Survival in Men with Advanced Prostate Cancer

February 03, 2012

SAN FRANCISCO—A novel medication may provide a new standard of care for the treatment of patients with castration-resistant prostate cancer (CRPC) and bone metastases, researchers reported here at the annual Genitourinary Cancers Symposium.
 

Obesity Raises Prostate Cancer Risk in All Races, Ethnicities

February 03, 2012

A new study suggests that obesity is associated with higher rates of prostate cancer screening across all races/ethnicities.
 

Ongoing Prostate Cancer Clinical Trials

Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Lucrin Depot in Patients With Advanced Prostate Cancer in Russia

Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer

The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer

Your Practice

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

On The Forefront


On The Forefront

In the past five to 10 years, researchers have developed several techniques to overcome donor incompatibility, including paired donation. The following case illustrates the collaborative efforts between nephrologists and urologists at the Glickman Urological and Kidney Institute.

Latest CME Article

Renal & Urology News includes a CME article in every print issue, which will also be available online.

View the latest installment:

Deceased Donor Transplantation

The Management of Patients After Renal Transplantation

Expert Q&A

Potential of FGF-23 Yet to Be Unleashed: An Interview with Orlando M. Gutiérrez, MD

Orlando M. Gutiérrez, MD

Orlando M. Gutiérrez, MD, Assistant Professor of Medicine in the Division of Nephrology at the University of Alabama at Birmingham, has studied fibroblast growth factor 23 (FGF-23) in depth, which may one day be an important marker of early-stage CKD.
Popular Topics
Acute Kidney Injury Anemia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease CKD Diabetes Epidemiology Erectile Dysfunction Hemodialysis Hyperphosphatemia Hypertension Infection Kidney Cancer Kidney Stones Nutrition Overactive Bladder Peritoneal Dialysis Prostate Cancer PSA Reproductive Medicine Transplantation Urinary Incontinence UTI

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions